Target intelligence / Profile preview

Yellow fever virus receptors

Molecular classification
Receptor, Cell adhesion molecule, Kinase, Chaperone, C-type lectin
01

Overview

The host cell receptors for YF-VAX (the 17D strain of the Yellow Fever Virus) are a collection of cell surface molecules that facilitate viral attachment and internalization. The primary receptors and attachment factors identified include AXL receptor tyrosine kinase (AXL), T-cell immunoglobulin and mucin domain-1 (TIM-1), and the C-type lectin DC-SIGN (CD209), which is crucial for the infection of dendritic cells (Lozach et al., 2005; Meertens et al., 2012). These receptors often utilize a mechanism known as apoptotic mimicry, where the virus binds to host proteins like Gas6 that recognize phosphatidylserine on the viral envelope, subsequently engaging TAM receptors like Axl to trigger endocytosis (Jemielity et al., 2013). Additionally, the chaperone protein GRP78 (HSPA5) has been identified as a co-receptor that interacts with the viral envelope protein to mediate entry (Nain et al., 2017). Because YF-VAX is a live-attenuated vaccine, its ability to infect host cells via these receptors is essential for the replication required to elicit a protective immune response. While these proteins are the natural entry points for the virus, they are also investigated as potential therapeutic targets for antiviral strategies aimed at blocking viral entry during acute infection. Heparan sulfate also serves as an initial attachment factor, concentrating the virus on the cell surface before it engages more specific entry receptors. The diversity of these receptors allows the virus to infect a wide range of cell types, contributing to the systemic nature of the immune response generated by the vaccine.

Other names
Host cell receptors for Yellow Fever VirusYFV receptors17D vaccine receptorsAXL receptor tyrosine kinaseT-cell immunoglobulin and mucin domain-1 (TIM-1)CD209 (DC-SIGN)Glucose-regulated protein 78 (GRP78)Hepatitis A virus cellular receptor 1 (HAVCR1)
02

Mechanism of action

Viral attachment and receptor-mediated endocytosis

03

Biological functions

Viral entryEndocytosisImmune responseCell signalingApoptotic cell clearance
04

Disease associations

Infection
05

Safety considerations

Potential for off-target effects due to the broad physiological roles of these receptors in immune homeostasis and efferocytosisRisk of systemic inflammatory response if receptors are modulated globally
06

Interacting drugs

YF-VAX

1 more in the full profile.

07

Biomarkers

CD209 expressionAXL expressionHAVCR1 expression

Beyond the preview

Go deeper on Yellow fever virus receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yellow fever virus receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call